PEAK6’s iShares Biotechnology ETF IBB Stock Holding History

PEAK6’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$571K	Buy	+3,000	New	+$516K	﹤0.01%	1919
2026 Q1	–	Sell	-1,300	Closed	-$219K	–	2971
2025 Q4	$219K	Sell	1,300 -24,000	-95%	-$3.9M	﹤0.01%	2364
2025 Q3	$3.65M	Sell	25,300 -100,000	-80%	-$13.6M	0.01%	1187
2025 Q2	$15.9M	Buy	125,300 +100,000	+395%	+$12.3M	0.03%	457
2025 Q1	$3.24M	Sell	25,300 -8,700	-26%	-$1.18M	0.01%	1159
2024 Q4	$4.5M	Buy	+34,000	New	+$4.78M	0.01%	964

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

PEAK6's IBB Position: Q2 2026 in Review

PEAK6 sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 3 shares — an estimated $516 sold.

PEAK6 first reported a position in IBB in Q4 2024 and held it in 2 quarters. The position peaked at $983K in Q4 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

PEAK6 reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
PEAK6 sold 3 iShares Biotechnology ETF shares in Q2 2026, an estimated $516.
PEAK6 first reported a position in iShares Biotechnology ETF in Q4 2024 and held it in 2 quarters.
PEAK6's iShares Biotechnology ETF position peaked at $983K in Q4 2024.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.